Preclinical and first-in-human evaluation of <sup>18</sup>F-labeled D-peptide antagonist for PD-L1 status imaging with PET.
Ming ZhouXiaobo WangBei ChenShijun XiangWanqian RaoZhe ZhangHuanhuan LiuJianyang FangXiaoqin YinPengbo DengXianzhong ZhangShuo HuPublished in: European journal of nuclear medicine and molecular imaging (2022)
<sup>18</sup>F-NOTA-NF12 was developed successfully as a PD-L1-specific tracer with promising results in preclinical and first-in-human trials, which support the further validation of <sup>18</sup>F-NOTA-NF12 for PET imaging of PD-L1 status in clinical settings.